XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,128,000 | +0.6% | 460,500 | +67.2% | 0.17% | +10.4% |
| Q2 2021 | $1,121,000 | -58.0% | 275,500 | -53.4% | 0.15% | -61.2% |
| Q1 2021 | $2,666,000 | -21.9% | 591,088 | -14.8% | 0.40% | -24.1% |
| Q4 2020 | $3,414,000 | -32.5% | 693,870 | -18.7% | 0.52% | -42.2% |
| Q3 2020 | $5,059,000 | +639.6% | 853,132 | +231.8% | 0.90% | +532.9% |
| Q2 2020 | $684,000 | – | 257,132 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |